1. American Cancer Society Cancer facts and figures 2005. American Cancer Society Web site. Available at: http://www.cancer.org/downloads/STT/CAFF/CAFF2005f4PWSecured.pdf. Accessed May 10, 2005.
2. SEER cancer statistics review, 1973–1999. Surveillance, Epidemiology and End Results (SEER) Web site. Available at: http://seer.cancer.gov/csr/1973_1999/prostate.pdf. Accessed November 18, 2004
3. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer;Bubley;J Clin Oncol,1999
4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
5. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004